Login to Your Account



Pharma: Other News To Note


Monday, June 18, 2012
• Meda AB, of Goteborg, Sweden, reported that Edluar has received registration approval in Europe, via the decentralization process, to treat sleep disorders. National registration processes will follow in each country, with the first launches expected early next year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription